載入...
Conflicting cerebrospinal fluid biomarkers and progression to dementia due to Alzheimer’s disease
BACKGROUND: According to new diagnostic guidelines for Alzheimer’s disease (AD), biomarkers enable estimation of the individual likelihood of underlying AD pathophysiology and the associated risk of progression to AD dementia for patients with mild cognitive impairment (MCI). Nonetheless, how confli...
Na minha lista:
| 發表在: | Alzheimers Res Ther |
|---|---|
| Main Authors: | , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BioMed Central
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5146856/ https://ncbi.nlm.nih.gov/pubmed/27931251 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13195-016-0220-z |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|